European equities traded in the US as American depositary receipts rose Wednesday with the S&P Europe Select ADR Index gaining 1.9% to 1,858.59.
From continental Europe, the gainers were led by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biopharmaceutical company Grifols (GRFS), which rose 3.5% and 3.3%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and medical device maker EDAP TMS (EDAP), which were up 2.4% and 0.6%, respectively.
The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and telecommunications company Nokia (NOK), which fell 3% and 1.4%, respectively. They were followed by internet advertising firm Criteo (CRTO) and software company SAP (SAP), which were down 1% and 0.9%, respectively.
The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which climbed 7.1% and 4%, respectively. They were followed by lenders Barclays (BCS) and Lloyds Banking Group (LYG), which each rose 3.4%.
The decliners from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which lost 1.3% and 1%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), down 0.9% and 0.5%, respectively.